Startup India Government of India
Orvil Pharmaceuticals Private Limited
Orvil Pharmaceuticals Private Limited - pharma in Howrah, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹87.16 Lakh
▼ 18% YoY
Net profit · FY 2025
₹58,090
Net margin 0.7%
EBITDA · FY 2025
₹94,310
EBITDA margin 1.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Orvil Pharmaceuticals Private Limited
Data last updated:
Orvil Pharmaceuticals Private Limited is a private limited company based in Howrah, West Bengal, India, recognised as a startup by DPIIT. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 May 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74999WB2017PTC221025.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Soumen Prabhat Sarkar and Nilima Sarkar Soumen.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bl – VII;3rd Floor;Fl – 3J 321/A G.T Road (Belur) Lp – 1/69 Howrah 711202, West Bengal, India – 711202.
As per the financials filed for FY 2025, the company reported a revenue of ₹87.16 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹58,090 (net margin 0.7%) and EBITDA of ₹94,310 (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 36% over three years and 25% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U74999WB2017PTC221025
Registration Number 221025
Incorporation Date 18 May 2017
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Orvil Pharmaceuticals
Contact details
Orvil Pharmaceuticals Private Limited's registered office is in Howrah, West Bengal. Its e-mail address is in the company report.
- Email
- Registered AddressBl – VII;3rd Floor;Fl – 3J 321/A G.T Road (Belur) Lp – 1/69 Howrah 711202, West Bengal, India – 711202
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Orvil Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Orvil Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Orvil Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers retail trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 47 | Retail trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Orvil Pharmaceuticals Private Limited, buy the company report.
Financials of Orvil Pharmaceuticals Private Limited
FY 2025 filings availableOrvil Pharmaceuticals Private Limited reported revenue of ₹87.16 Lakh (down 18% YoY) for FY 2025.
Revenue · FY 2025
₹87.16 Lakh ▼ 18%
Net profit · FY 2025
₹58,090 margin 0.7%
EBITDA · FY 2025
₹94,310 margin 1.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 36%
5 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▼ 82%
3 years · compounded
▼ 11%
5 years · compounded
▲ 1%
Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 25%. EBITDA fell 82% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹94,310 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹58,090 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Orvil Pharmaceuticals Private Limited, buy the company report.
Board of directors of Orvil Pharmaceuticals Private Limited
Orvil Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Soumen Prabhat Sarkar | Director | 18 May 2017 | 9 Years 5 Months | Current |
| Nilima Sarkar Soumen | Additional Director | 02 Jan 2018 | 8 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Orvil Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Orvil Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Orvil Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Orvil Pharmaceuticals Private Limited has 3 board changes on record since 2017: 2 appointments and 1 cessation. The latest: Aniruddha Bhowmick ceased to be Director on 10 Jan 2018.
AGM
Orvil Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Orvil Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata Ii.
Ceased
Aniruddha Bhowmick ceased to be Director.
Appointed
Nilima Sarkar Soumen was appointed as Additional Director.
Appointed
Soumen Prabhat Sarkar was appointed as Director.
Incorporation
18 May 2017
Orvil Pharmaceuticals Private Limited was registered on 18 May 2017 with Roc Kolkata Ii & aged 9 years 5 months as per MCA records.
Frequently asked questions
Orvil Pharmaceuticals is an active private limited company based in Howrah, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 May 2017 (9+ years old) and is registered under CIN U74999WB2017PTC221025.
Orvil Pharmaceuticals has 2 current directors:
- Soumen Prabhat Sarkar - Director
- Nilima Sarkar Soumen - Additional Director
The latest financial statements of Orvil Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The CIN (Corporate Identification Number) of Orvil Pharmaceuticals is U74999WB2017PTC221025. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Orvil Pharmaceuticals was incorporated on 18 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kolkata.
Aniruddha Bhowmick ceased to be Director on 10 Jan 2018. Nilima Sarkar Soumen was appointed as Additional Director on 02 Jan 2018. Soumen Prabhat Sarkar was appointed as Director on 18 May 2017.
Yes, Orvil Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Orvil Pharmaceuticals is at Bl – VII;3rd Floor;Fl – 3J 321A G.T Road Belur Lp – 169 Howrah 711202, West Bengal, India – 711202.
Orvil Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Orvil Pharmaceuticals is compliant as of 09 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages